Adenovirus vector bearing the CFTR gene: Began a Phase I safety trial in up to 26 patients, using repeated dosing in the large airways of the lung. The trial is

GenVec, Rockville, Md.
Product:

Read the full 46 word article

How to gain access

Continue reading with a
two-week free trial.